T2DM is thought to develop as a combination of insulin resistance and pancreatic β-cell failure.1 Therefore, identification of novel treatments that would increase pancreatic insulin secretion while protecting pancreatic β-cells is of great interest. Here, INS is linked to type 2 diabetes mellitus.